Youâre reading a free article with opinions that may differ from The Motley Foolâs Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.
RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partnerâs brokerage products, these are focused on the trading of readily releasable securities.
Owain Bennallack is joined by Mark Rogers and Nate Weisshaar to discuss whether revelations about a covertly filmed sex tape really matter in the long-running fraud saga faced by GlaxoSmithKline (LSE: GSK) in China.
The scandal continues with a look at the latest allegations leveled at embattled bank Barclays (LSE: BARC), before the team moves on to calmer waters to consider whether the higher annual allowances now in force for ISAs make them superior to pensions.
Plus three shares the team are watching right now: Rightmove (LSE: RMV), Ocado (LSE: OCDO) and Berkeley Group (LSE: BKG).
